Prevalence of Hepatitis A, Hepatitis B, and HIV Among Hepatitis C–Seropositive State Hospital Patients: Results From Oregon State Hospital
J Clin Psychiatry 2003;64(5):540-545
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Multiple studies have shown
that individuals with severe mental illness are at increased risk
for acquiring infection from human immunodeficiency virus (HIV),
hepatitis B virus (HBV), and hepatitis C virus (HCV). Moreover,
patients with chronic HCV infection are at risk for fulminant
hepatitis from acquired infection with hepatitis A virus (HAV) or
HBV, but there are limited data on the prevalence of HIV, HAV,
and HBV in chronically hospitalized U.S. psychiatric patients
without mental retardation who are HCV-seropositive. To address
this issue, a comprehensive screening program was commenced at
Oregon State Hospital (Salem, Ore.) beginning in 1999.
Method: The computerized records of all
nongeriatric adult inpatients at Oregon State Hospital on April
23, 2001, were reviewed to assess physician compliance with
screening and the prevalence of infection with HIV, HAV, HBV, and
Results: Among the 535 patient records reviewed,
94.8% of patients were screened for HCV, of whom 20.3% were
seropositive. Among HCV-seropositive patients, only 1.9% were not
screened for HAV and HBV, but 23.3% were not tested for HIV. In
the HCV-seropositive group, 35.9% were HAV-positive, 49.5%
HBV-positive, and 2.6% HIV-positive.
Conclusion: Chronic psychiatric inpatients have
high HCV prevalence rates. Hepatitis C-seropositive individuals
may be at risk for complications unless vaccinated for HAV and